Product
T-1201
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase I, Open-label, Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of T-1201 Injection 100 mg Kit in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-06-30